NIFTY  8,947.40  0.09%
  SENSEX  28,933.20  0.14%
 CURRENCY  Rs  66.83/$ 70.65/€, 83.79/£
  GOLD  29,640.00  0.64%
  SILVER  43,310.00  1.06%
  DAX  11,804.00  -1.20%
  FTSE  7,243.70  -0.38%
  CAC  4,845.24  -0.79%
  HANG SENG  23,965.70  -0.62%
  NIKKEI  19,283.50  -0.45%
  Shanghai Composite  3,253.43  0.04%
  DOW JONES  20,821.80  0.06%
  NASDAQ  5,845.31  0.17%
  S&P 500  2,367.34  0.15%
STOCK ALERT : RIL Was Last At Rs 1250/Share In May 2009 STOCK ALERT : RIL's Market Capitalisation Crosses Rs 4 Lakh Cr STOCK ALERT : FIIs Increased Stake In Co By 3% In Q3FY17 STOCK ALERT : Domestic MFs Have Been Buying RIL Post TP Hiked By Most Brokerages STOCK ALERT : Most Domestic MFs Underowned The Stock

USFDA Hit For Ranbaxy

Video:

Play this video

September 16: The USFDA has issued an import alert against Ranbaxy and says that it will not be able to import drugs produced at its Mohali unit. While the order does not have a significant financial impact on the company, it has dampened sentiment as the unit was being primed for new launches. Bloomberg TV India discusses how this ban raises doubts about the launch of some of the company’s key exclusive drugs.